Zinbryta (Abbvie)
Welcome to the PulseAid listing for the Zinbryta drug offered from Abbvie. This Interleukin 2 Receptor Antagonists [MoA],Interleukin 2 Receptor-directed Antibody Interactions [MoA],Interleukin-2 Receptor Blocking Antibody [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Abbvie |
| NON-PROPRIETARY NAME: | Daclizumab |
| SUBSTANCE NAME: | DACLIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin 2 Receptor Antagonists [MoA],Interleukin 2 Receptor-directed Antibody Interactions [MoA],Interleukin-2 Receptor Blocking Antibody [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-05-27 |
| END MARKETING DATE: | 0000-00-00 |
Zinbryta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zinbryta from Abbvie |
| LABELER NAME: | Abbvie |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/mL) |
| START MARKETING DATE: | 2016-05-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-0033_78f3fa21-13f6-4f2e-b6bd-d786270d1a7d |
| PRODUCT NDC: | 0074-0033 |
| APPLICATION NUMBER: | BLA761029 |
Other DACLIZUMAB Pharmaceutical Manufacturers / Labelers:
